Clinical trials
Observational Anosmia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Michael J. Fox Foundation for Parkinson's Research | 2 |
| National Institute on Drug Abuse (NIDA) | 2 |
| Metamorphosis LTD | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 1 |
| National Institute on Deafness and Other Communication Disorders (NIDCD) | 1 |
| Northwestern University | 1 |
| Purdue University | 1 |
| Rockefeller University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anosmia | 15 |
| Obesity | 3 |
| Parkinson Disease | 3 |
| Influenza, Human | 2 |
| Neurodegenerative Diseases | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
| Substance-Related Disorders | 2 |
| Alzheimer Disease | 1 |
| Asthma | 1 |
| Autonomic Nervous System Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.